-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Amneal Pharmaceuticals, Inc. annual/quarterly Depreciation history and growth rate from Q2 2017 to Q3 2018.
- Amneal Pharmaceuticals, Inc. Depreciation for the quarter ending September 30, 2018 was $17.4M, a 62.5% increase year-over-year.
- Amneal Pharmaceuticals, Inc. annual Depreciation for 2023 was $66.2M, a 2.79% decline from 2022.
- Amneal Pharmaceuticals, Inc. annual Depreciation for 2022 was $68.1M, a 12.2% increase from 2021.
- Amneal Pharmaceuticals, Inc. annual Depreciation for 2021 was $60.7M, a 0.46% increase from 2020.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)